RhIGF-1 is the recombinant form of insulin-like growth factor-1, and has been researched for its potential in mitigating growth hormone (GH) insensitivity
September 1, 2024: Kentucky Woman Files Lawsuit Alleging Ozempic Caused Gastroparesis On August 27, 2024, a 43-year-old Kentucky woman filed an Ozempic lawsuit, alleging that the GLP-1 drugs caused her gastroparesis, or stomach paralysis
Co-treatment with Erastin showed severe muscle fiber disruption, significantly increased fibrosis, and extensive collagen deposition
This alpha-cell expansion has been associated with the development of pancreatic neuroendocrine tumors
Encouraging results from phase IIa and IIb studies have paved the way for phase III clinical trials 6
We propose that long-term extra sugar intake multiple times a day can gradually sweep the -cells away, and suggest that simultaneously taking glutathione, an antioxidant, in each meal could prevent blood glucose/ROS-induced detrimental effects on -cell